Silver Book Fact

New medicines, or “new chemical entities” accounted for 40% (0.8 years) of the two-year gain in life expectancy seen in 52 countries from 1986-2000.

Lichtenberg, Frank R. The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. National Bureau of Economic Research. June 2003; Working Paper No. 9754. http://www.nber.org/papers/w9754

Reference

Title
The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001
Publication
National Bureau of Economic Research
Publication Date
June 2003
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Improvements in preventing and managing chronic disease could reduce future economic costs in the United States by 27% ($1.1 trillion) in 2023. $905 billion would come from gains in productivity;…  
  • Increased longevity added about $3.2 trillion per year to national wealth between 1970 and 2000, an uncounted value equal to approximately 1/2 of the average annual GDP during that period.  
  • Using newer drugs could lower overall health expenses by as much as $111 per person, per condition, for the general population, and $155 for Medicare beneficiaries.  
  • Analysis suggests that in the past 20 years, each additional dollar spent on health care services produced health gains valued at between $2.40 and $3.00.  
  • Private health insurance benefit spending is predicted to slow from a peak of 9.5% in 2001 to 4.7% in 2006, partially because of Medicare Part D.